Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: JOEBT1 who wrote (13464)	1/18/1998 11:30:00 PM
From: Russian Bear	Read Replies (1) \| Respond to of 32384

Hi, JOEBT1, I, also, wondered about whether Farallon would consent to eating the 1.5 to 2 points of time premium, rather than to box the position and wait it out. On reflection, I decided that Henry is probably right: Farallon is getting out and leaving the premium on the table. Here is my reasoning: There are two choices: (1) take approximately $5.25 per warrant, right now, and run, or (2) short an equal number of LGND, and lock-up $7.125 in approximately 2.4 years, as you suggested. Running the numbers, case (2) works out to an annual rate of return of less than 14%, even if the carrying costs of the short position were zero (an unlikely assumption.) In any event, I suspect that this is an unacceptably low target rate of return for a hedge fund (25% would be my guess for their threshold of acceptability.) One way or the other, we do not have long to wait to learn the truth: by this date, February, we should see the new short interest numbers, as well as Farallon's SEC filings, assuming that a substantive change really has occured in its position. Good luck, RB